FFF Enterprises Signs Flu Vaccine Agreement with GlaxoSmithKline

December 6, 2005 Media Release

Biopharmaceutical supply channel innovator receives U.S. distribution deal

TEMECULA, Calif. - FFF Enterprises Inc., a healthcare corporation based in Temecula, Calif., today announced that GlaxoSmithKline (GSK) has awarded FFF a contract for the U.S. distribution of GSK's influenza vaccine Fluarix™, for the 2006-2007 season. FFF helped launch Fluarix in the United States, as a preferred distributor during the current 2005-2006 flu season.

"This new agreement is truly an honor," said Patrick M. Schmidt, FFF's president and CEO. "It culminates the first season of our relationship with GSK, during which we've been able to help the company successfully launch GSK's new brand for early delivery in the United States. Our customers have accepted Fluarix, and satisfaction appears quite high. Now we look forward to working with the GSK team again - they are great partners!"

FFF's manufacturing partners appreciate the company's unique distribution business model, which assures that their products move only from the manufacturer to FFF to healthcare providers, protecting the product - and healthcare consumers - from the risks and irresponsible pricing of secondary and gray pharmaceutical market transactions.

"FFF and our manufacturing partners remain dedicated to a well-defined and responsible channel for our patients' safety and for the protection of our partners' valuable brands," Schmidt concluded.

About FFF Enterprises
FFF Enterprises was founded in 1988 and has since grown into a multidimensional healthcare company, delivering innovative solutions in biopharmaceutical management and distribution, health information management and consumer healthcare services. FFF is now the nation's largest supplier of biopharmaceuticals, plasma products, vaccines and clinical trial drugs. Customers of FFF's four divisions include members of the leading U.S. acute care and non-acute care group purchasing organizations, pharmaceutical manufacturers, contract research organizations, managed healthcare and consumers.

FFF's unique distribution business model has institutionalized Guaranteed Channel Integrity™, which reflects the company's commitment to purchase only from manufacturers and ship only to healthcare providers. This protects products from secondary and gray markets and promotes patient safety.